Skip to 0 minutes and 6 secondsAfter an introduction to nanotechnology and the role it will play in future health care, last week we introduced to you the artificial nose, which is an example of such a new development. The topic of the upcoming week is a so-called lab on a chip device. With such a device, you can do a fast, detailed, and accurate analysis of one single drop of blood. It's like a miniature laboratory. We will explain to you the basic working principles of this technology. Apart from applications in medical diagnostics, these lab on a chip devices can furthermore be applied in several other application fields. Other researchers at our university have, for example, used the same technology to measure calcium in the blood of milk cows.
Skip to 0 minutes and 54 secondsThe main lecturer of this week is Professor Jan Eijkel. He is involved in several lab on a chip research programs at our university.
Welcome to week 3
Welcome to the third week of this course. The topic of this week is lab-on-a-chip technology for the detection of biomarkers in blood.
Your main lecturer this week is Prof. Jan Eijkel, who is working in the BIOS Lab-on-a-chip research group, at the University of Twente. His personal focus in this field is on nanofluidics in lab on a chip applications. He will start with a basic explanation about ions in water, and how ions can be linked with diseases. Then he works towards the concept of the lab-on-chip, explain how this lab-on-a-chip device is able to separate ions (a process called electrophoresis) and detect them.
Jan Eijkel will also explain the fabrication of these great lab-on-a-chip devices, step by step. Steven Staal, cofounder of Medimate, will explain how his company has developed this technology into an electrophoresis self test. Patients only need to add one single drop of blood to get a reading.
In this week we further discuss the shifts in role and responsibilities. Technologies such as point-of-care lab-on-a-chip devices for medical treatment, will inevitably lead to the generation of information by the patient instead of a medical professional. What are the consequences and should we do this in all cases? Finally we talk about patents and stakeholders, both very important when you want to bring an idea to the market.
© University of Twente